Your session is about to expire
← Back to Search
THC (Dronabinol) for Sleep Issues in Cannabis Users
Study Summary
This trial will study the effects of oral THC on sleep in people who don't often and those who often use cannabis.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been treated with antidepressants, neuroleptics, or tranquilizers.I do not use drugs, alcohol, caffeine, or nicotine and can avoid them during the study.I do not have symptoms like fever or a high white blood cell count.I am currently taking prescribed or over-the-counter medications.I have diabetes.I have a history of seizures.I suffer from long-term pain.I have severe liver problems.I have been diagnosed with sleep apnea.I have a heart condition.I have not traveled across more than 2 time zones in the last month.You have never used cannabis more than 10 times in your life.
- Group 1: Non Cannabis Users
- Group 2: Frequent Cannabis Users
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For which ailments is Dronabinol typically prescribed?
"Dronabinol is frequently used as a means of ameliorating weight loss and can also be deployed to address inadequate response to conventional treatment regimens, pharmacotherapy, and anorexia."
Are there any unfilled slots available for this research endeavor?
"This research is no longer accepting applications. It was posted on September 1st 2018 and last updated May 27th 2022. For those in search of other studies, 271 trials are currently onboarding participants for cannabis-based treatments while 38 clinical trials are taking partakers with Dronabinol."
What is the enrollment capacity of this medical research study?
"At this moment, enrollment for this particular trial is closed. It was initially announced on September 1st of 2018 and edited most recently on May 27th 2022. For individuals looking to participate in other research studies, there are presently 271 trials that involve marijuana and 38 more for dronabinol actively recruiting volunteers."
Are there any other experiments that have been conducted to explore the potential of Dronabinol?
"Presently, there are 38 separate studies for Dronabinol with 6 of them at the advanced Phase 3 level. Belmont, Massachusetts is home to many of those trials, but a total of 90 medical centres across the United States are running such research."
Is the age limit for volunteers of this research project greater than forty years?
"This trial only admits those between 21 to 34 years of age. For younger and older patients, there are 47 and 162 trials respectively available for them."
Who qualifies to partake in this medical study?
"Qualified individuals for this study must have a history of marijuana use and be between 21-34 years old. Currently, the team is recruiting around 18 participants."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger